Success Metrics

Clinical Success Rate
93.2%

Based on 552 completed trials

Completion Rate
93%(552/592)
Active Trials
138(14%)
Results Posted
6%(31 trials)
Terminated
40(4%)

Phase Distribution

Ph early_phase_1
3
0%
Ph phase_1
8
1%
Ph phase_2
16
2%
Ph phase_3
6
1%
Ph phase_4
5
1%
Ph not_applicable
153
16%

Phase Distribution

11

Early Stage

16

Mid Stage

11

Late Stage

Phase Distribution191 total trials
Early Phase 1First-in-human
3(1.6%)
Phase 1Safety & dosage
8(4.2%)
Phase 2Efficacy & side effects
16(8.4%)
Phase 3Large-scale testing
6(3.1%)
Phase 4Post-market surveillance
5(2.6%)
N/ANon-phased studies
153(80.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

552 of 613 finished

Non-Completion Rate

10.0%

61 ended early

Currently Active

138

trials recruiting

Total Trials

970

all time

Status Distribution
Active(176)
Completed(552)
Terminated(61)
Other(181)

Detailed Status

Completed552
unknown178
Recruiting100
Terminated40
Active, not recruiting38
Not yet recruiting29

Development Timeline

Analytics

Development Status

Total Trials
970
Active
138
Success Rate
93.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (1.6%)
Phase 18 (4.2%)
Phase 216 (8.4%)
Phase 36 (3.1%)
Phase 45 (2.6%)
N/A153 (80.1%)

Trials by Status

unknown17818%
terminated404%
not_yet_recruiting293%
active_not_recruiting384%
recruiting10010%
enrolling_by_invitation91%
suspended30%
withdrawn212%
completed55257%

Recent Activity

Clinical Trials (970)

Showing 20 of 970 trialsScroll for more
NCT05163171

Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)

Completed
NCT02361320Not Applicable

Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer

Recruiting
NCT04254133

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Enrolling By Invitation
NCT00684437Not Applicable

Literacy and Smoking Risk Communications

Active Not Recruiting
NCT06140069

Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.

Withdrawn
NCT07490509Phase 4

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

Not Yet Recruiting
NCT05076266

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Terminated
NCT07701733

A Study of Lung Cancer Risk

Recruiting
NCT07469007Not Applicable

Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO)

Recruiting
NCT01008787Not Applicable

Motivational Interviewing for Physical Activity

Active Not Recruiting
NCT00618553Phase 2

Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting

Active Not Recruiting
NCT06745076Phase 2

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Recruiting
NCT03214510Phase 3

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Active Not Recruiting
NCT05748314

Marfan Syndrome and Quality of Life of Pediatric Patients

Active Not Recruiting
NCT07356557

Evaluation of Therapeutic Adherence Among Patients Followed in the Department of Hereditary Metabolic Diseases at Necker Hospital

Recruiting
NCT06357130

Gynaecological Care for Transgender People in France in 2024.

Completed
NCT05890417Not Applicable

Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy

Completed
NCT05125887

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)

Completed
NCT07666100

Evaluation of Adverse Effects Related to Prescribed Medications in a Periodontology Clinic

Recruiting
NCT00589654

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
970